{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:03:56Z","timestamp":1762160636938},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Exper.Med."],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s10238-007-0124-0","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T12:42:57Z","timestamp":1183466577000},"page":"39-46","source":"Crossref","is-referenced-by-count":7,"title":["Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin\u2019s lymphomas"],"prefix":"10.1007","volume":"7","author":[{"given":"H.","family":"Kamata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,4]]},"reference":[{"key":"124_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(08)60785-X","volume":"77","author":"P. Hainaut","year":"2000","unstructured":"Hainaut P, Hollstein M (2000) p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77:81\u201337","journal-title":"Adv Cancer Res"},{"key":"124_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"A.J. Levine","year":"1997","unstructured":"Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323\u201331","journal-title":"Cell"},{"key":"124_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1126\/science.2683079","volume":"246","author":"L.H. Hartwell","year":"1989","unstructured":"Hartwell LH, Weinert TA (1989) Checkpoints: controls that ensure the order of cell cycle events. Science 246:629\u201334","journal-title":"Science"},{"key":"124_CR4","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/MCB.6.5.1379","volume":"6","author":"P. Lamb","year":"1986","unstructured":"Lamb P, Crawford LV (1986) Characterization of the human p53 gene. Mol Cell Biol 6:1379\u2013385","journal-title":"Mol Cell Biol"},{"key":"124_CR5","first-page":"4855","volume":"54","author":"M.S. Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855\u2013878","journal-title":"Cancer Res"},{"key":"124_CR6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/nar\/24.1.141","volume":"24","author":"M. Hollstein","year":"1996","unstructured":"Hollstein M, Shomer B, Greenblatt M et al (1996) Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24:141\u201346","journal-title":"Nucleic Acids Res"},{"key":"124_CR7","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/emboj\/17.7.1847","volume":"17","author":"R.K. Brachmann","year":"1998","unstructured":"Brachmann RK, Yu K, Eby Y et al (1998) Genetics selection of intragenic suppressor mutations that reverse the effects of common p53 cancer mutations. EMBO J 17:1847\u2013859","journal-title":"EMBO J"},{"key":"124_CR8","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","volume":"84","author":"J. Imamura","year":"1994","unstructured":"Imamura J, Miyoshi I, Koeffler HP (1994) p53 in hematologic malignancies. Blood 84:2412\u2013421","journal-title":"Blood"},{"key":"124_CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M. Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutation in human cancers. Science 253:49\u20133","journal-title":"Science"},{"key":"124_CR10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","volume":"342","author":"J.M. Nigro","year":"1989","unstructured":"Nigro JM, Baker SJ, Preisinger AC et al (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705\u201308","journal-title":"Nature"},{"key":"124_CR11","first-page":"4273","volume":"52","author":"K.G. Bhatia","year":"1992","unstructured":"Bhatia KG, Gutierrez MI, Huppi K, Siwarski D (1992) The pattern of p53 mutations in Burkitt\u2019s lymphoma differs from that of solid tumor. Cancer Res 52:4273\u2013276","journal-title":"Cancer Res"},{"key":"124_CR12","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","volume":"88","author":"G. Gaidano","year":"1991","unstructured":"Gaidano G, Ballerini P, Gong JZ et al (1991) p53 mutation in human lymphoid malignancies: association with Burkitt\u2019s lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 88:5413\u2013417","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR13","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V79.10.2701.bloodjournal79102701","volume":"79","author":"A. Ichikawa","year":"1992","unstructured":"Ichikawa A, Hotta T, Takagi N et al (1992) Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 79:2701\u2013707","journal-title":"Blood"},{"key":"124_CR14","first-page":"945","volume":"5","author":"T. Soussi","year":"1990","unstructured":"Soussi T, Caron de Fromentel C, May P (1990) Structural aspect of the p53 protein in relation to gene evolution. Oncogene 5:945\u201352","journal-title":"Oncogene"},{"key":"124_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"A.J. Levine","year":"1991","unstructured":"Levine AJ, Momand J, Finlay CA (1991) The p53 tumor suppressor gene. Nature 351:453\u201356","journal-title":"Nature"},{"key":"124_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/humu.1380030207","volume":"3","author":"J.M. Pignon","year":"1994","unstructured":"Pignon JM, Vinatier I, Fanen P et al (1994) Exhaustive analysis of the 53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemia. Hum Mutat 3:126\u201332","journal-title":"Hum Mutat"},{"key":"124_CR17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2141.1997.2403057.x","volume":"98","author":"C. Preudhomme","year":"1997","unstructured":"Preudhomme C, Fenaux P (1997) The clinical significance of mutations of the p53 suppressor gene in haematological malignancies. Br J Hematol 98: 502\u201311","journal-title":"Br J Hematol"},{"key":"124_CR18","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood.V80.12.3205.3205","volume":"80","author":"E. Cesarman","year":"1992","unstructured":"Cesarman E, Chadburn A, Inghirami G et al (1992) Structural and functional analysis of oncogene and tumor suppressor genes in adult T-cell leukemia \/lymphoma shows frequent p53 mutations. Blood 80:3205\u2013216","journal-title":"Blood"},{"key":"124_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","volume":"79","author":"A. Sakasita","year":"1992","unstructured":"Sakasita A, Hattori T, Miller CW et al (1992) Mutations of the p53 gene in adult T cell leukemia. Blood 79:477\u201380","journal-title":"Blood"},{"key":"124_CR20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","volume":"10","author":"N.L. Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J et al (1999) The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues. Ann Oncol 10:1419\u2013432","journal-title":"Ann Oncol"},{"key":"124_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1084\/jem.167.1.225","volume":"167","author":"D.K. Shibata","year":"1988","unstructured":"Shibata DK, Arnheim N, Martin WJ (1988) Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med 167:225\u201330","journal-title":"J Exp Med"},{"key":"124_CR22","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1126\/science.4071043","volume":"230","author":"R.M. Myers","year":"1985","unstructured":"Myers RM, Larin Z, Maniatis T (1985) Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA-DNA duplexes. Science 230:1242\u2013246","journal-title":"Science"},{"key":"124_CR23","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1073\/pnas.82.22.7575","volume":"82","author":"E. Winter","year":"1985","unstructured":"Winter E, Yamamoto F, Almohuera C, Perucho M (1985) A method to detect and characterize point mutation in transcribed genes. Proc Natl Acad Sci U S A 82:7575\u2013579","journal-title":"Proc Natl Acad Sci U S A"},{"key":"124_CR24","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood.V88.10.4012.bloodjournal88104012","volume":"88","author":"M. Chilosi","year":"1996","unstructured":"Chilosi M, Doglioni C, Magalini A et al (1996) p21\/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin\u2019s lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood 88:4012\u2013020","journal-title":"Blood"},{"key":"124_CR25","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood.V89.7.2523","volume":"89","author":"R. Maestoro","year":"1997","unstructured":"Maestoro R, Gloghini A, Doglioni C et al (1997) Human non-Hodgkin\u2019s lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclindependent kinase inhibitor p21. Blood 89:2523\u2013528","journal-title":"Blood"},{"key":"124_CR26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/bjc.1995.292","volume":"72","author":"D.J.A. Adamson","year":"1995","unstructured":"Adamson DJA, Thompson WD, Dawson AA et al (1995) p53 mutation and expression in lymphoma. Br J Cancer 72:150\u201354","journal-title":"Br J Cancer"},{"key":"124_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1034\/j.1600-0609.2003.00094.x","volume":"71","author":"C.E. Klumb","year":"2003","unstructured":"Klumb CE, Furtado DR, de Resende LMM et al (2003) DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin\u2019s lymphomas: prognostic implications. Eur J Haematol 71:81\u20130","journal-title":"Eur J Haematol"},{"key":"124_CR28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","volume":"337","author":"A. Ichikawa","year":"1997","unstructured":"Ichikawa A, Kinoshita T, Watanabe T et al (1997) Mutation of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 337:529\u201334","journal-title":"N Engl J Med"},{"key":"124_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0002-9440(10)61686-0","volume":"159","author":"M. Sanche-Beato","year":"2001","unstructured":"Sanche-Beato M, Saez AI, Navas IC et al (2001) Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alteration in p53, p16, and p27. Am J Pathol 159:205\u201313","journal-title":"Am J Pathol"},{"key":"124_CR30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/annonc\/mdf185","volume":"13","author":"K. Leroy","year":"2002","unstructured":"Leroy K, Haioun C, Lepage E et al (2002) p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas. Ann Oncol 13:1108\u2013115","journal-title":"Ann Oncol"},{"key":"124_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.8023157","volume":"265","author":"Y. Cho","year":"1994","unstructured":"Cho Y, Gorina S, Jeffrey PD, Pavletich NP (1994) Crystal structure of a p53 tumor Suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346\u201355","journal-title":"Science"},{"key":"124_CR32","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","volume":"90","author":"P.R. Koduru","year":"1997","unstructured":"Koduru PR, Raju K, Vadmal V et al (1997) Correlation between mutation in p53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin\u2019s lymphoma. Blood 90:4078\u2013091","journal-title":"Blood"},{"key":"124_CR33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1200\/JCO.1995.13.4.812","volume":"13","author":"C. Preudhomme","year":"1995","unstructured":"Preudhomme C, Dervite I, Wattel E et al (1995) Clinical significance of p53 mutations in newly diagnosed Burkitt\u2019s lymphoma and acute lymphoblastic leukemia: a report of 48 cases. J Clin Oncol 13:812\u201320","journal-title":"J Clin Oncol"},{"key":"124_CR34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35106009","volume":"1","author":"T. Soussi","year":"2001","unstructured":"Soussi T, Beroud C (2001) Assessing TP53 status in human tumours to evaluate clinical outcome. Natl Rev Cancer 1:233\u201339","journal-title":"Natl Rev Cancer"},{"key":"124_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0046-8177(98)90044-2","volume":"29","author":"M.L. Gulley","year":"1998","unstructured":"Gulley ML, Burton MP, Allred DC et al (1998) Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum Pathol 29:252\u201359","journal-title":"Hum Pathol"},{"key":"124_CR36","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","volume":"82","author":"C.A. Sander","year":"1993","unstructured":"Sander CA, Yano T, Clark HM et al (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994\u2013004","journal-title":"Blood"},{"key":"124_CR37","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","volume":"82","author":"F. Coco Lo","year":"1993","unstructured":"Lo Coco F, Gaidano G, Louie DC et al (1993) p53 mutation are associated with histologic transformation of follicular lymphoma. Blood 82:2289\u2013295","journal-title":"Blood"},{"key":"124_CR38","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood.V86.12.4587.bloodjournal86124587","volume":"86","author":"M.Q. Du","year":"1995","unstructured":"Du MQ, Peng HZ, Singh N et al (1995) The accumulation of p53 abnormality is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 86:4587\u2013593","journal-title":"Blood"},{"key":"124_CR39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/hupa.2001.21569","volume":"32","author":"B. Petit","year":"2001","unstructured":"Petit B, Leroy K, Kanavaros P et al (2001) Expression of p53 protein in T-and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum Pathol 32:196\u201304","journal-title":"Hum Pathol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-007-0124-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-007-0124-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-007-0124-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:25:36Z","timestamp":1587687936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-007-0124-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s10238-007-0124-0","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}